Maverick Advocaten assists Erasmus MC and IJsselland Hospital in obtaining second phase approval from ACM

Martijn van de Hel is assisting Erasmus MC and IJsselland Hospital in obtaining approval from the Netherlands Authority for Consumers & Markets ("ACM") for their proposed merger. On 1 April 2021, ACM held that a license is required for the merger. This license was applied for on 10 May 2021.

During the second phase investigation, ACM will conduct further investigation into the effects of the hospitals' cooperation plans on the market for patient care and the healthcare procurement market. An important question in ACM's investigation is to what extent Erasmus MC is in fact active on the market for basic care. For more information about the license application, read here and here.

Erasmus MC and IJsselland Hospital are both located in the greater Rotterdam area. Erasmus MC is the largest academic hospital in the Netherlands and has a national catchment area. IJsselland Hospital is a general hospital with a catchment area extending to Capelle aan den IJssel, Krimpen aan den IJssel, Nieuwerkerk aan den IJssel, Krimpenerwaard and the eastern side of Rotterdam. With their collaboration, the hospitals intend to implement the initiative called ‘De Juiste Zorg op de Juiste Plek'.

Maverick Advocaten regularly assists healthcare providers with mergers and acquisitions, see for example here, here, and here.

Follow Maverick Advocaten on Twitter and LinkedIn

Contact details

Martijn van de Hel

T +31 20 238 20 02
M +31 6 21 210 853